The abnormal involuntary movements seen in Huntington's disease, Parkinson's disease, tardive dyskinesia and athetoid cerebral palsy are presumed to result in part from dysfunction of the neostriatum (caudate nucleus and putamen) 1. These movements include chorea, athetosis, dystonia and bradykinesia. How neostriatal dysfunction leads to these symptoms is unknown. Except in Parkinson's disease, pharmacologic treatment of these abnormal movements has been disappointing. Occasionally, surgical therapy has proved successful especially when the surgical lesion is in the ventroanterior and ventrolateral nuclei (VL) of the thalamus 3. The success of these operations suggests that these abnormal movements are dependent on the integrity of VL. The part of VL which projects to motor cortex receives a major output from the basal ganglia via the medial segment of the globus pallidus (MPS) (Fig. 1, left side) 2,10. The MPS in turn receives output from neostriatal neurons which also send collaterals to the substantia nigra 14. Thus these pathways from neostriatum to ventroanterior and ventrolateral thalamus via the medial pallidal segment may play an important role in the generation of abnormal movements. The neurotransmitter of medial pallidal cells is unknown. We have recently attempted to demonstrate the neurotransmitter of the pallidothalamic pathway in rats by studying neurotransmitter functions in ventrolateral nucleus of the thalamus after injection of kainic acid into the murine counterpart of the medial pallidal segment, the entopeduncular nucleus (EP).
Kainic acid (Sigma), 0.1 M solution, pH 7.0, was iontophoresed stereotaxically into the right EP of Sprague-Dawley rats (150-200 g)lL Stereotaxic coordinates were A.P. --5.2 mm, M.L. --2.7 ram, D.V. --1.8 mm 1~. Angled injections from 30 ° forward, passing through prefrontal cortex, striatum and globus pallidus, were used. Negative current (1 mA) was passed through 40/zm tip glass micropipettes with 500
